Nevro Corp.

As of December 31, 2024, Nevro Corp. has 37.82M shares outstanding.

These figures are as of December 31, 2024. The price-to-sales ratio is 0.34, and the price-to-book ratio stands at -0.17.

These figures are as of December 31, 2024. The EV/Sales ratio of 0.24 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Nevro Corp. trades at an EV/FCF ratio of 5.52, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of December 31, 2024, Nevro Corp. maintains a current ratio of 4.62, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 108.72, indicating elevated leverage, while an interest coverage ratio of -3.00 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2024. Return on assets (ROA) is negative at -19.07, reflecting losses generated across the asset base. Inventory turnover of 1.25 indicates how many times Nevro Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on April 2, 2025, Nevro Corp.'s stock has declined approximately 54.12% over the past 52 weeks. The 50-day moving average sits at 5.61, while the 200-day moving average is 5.78.

Over the twelve months ended December 31, 2024, Nevro Corp. posted a gross margin of 65.98, reflecting its pricing power and cost economics. The operating margin of -23.18 and net profit margin of -27.77 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2024. Free cash flow yield is negative at -7.00: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 3.05, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Nevro Corp. shareholders.

Nevro Corp.'s most recent stock split took place on November 6, 2014 with a 24:1 split ratio.

As of December 31, 2024, Nevro Corp. has an Altman Z-Score of -0.87, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.